for the effects of passive smoking on smokers. Therefore the main emphasis of this paper is an estimation of the risks of passive smoking in lifelong non-smokers; data are presented for the active smoking groups to provtde an estimate of dose-response.
Design-Coded analysis of serum samples taken from patients with carefully defined alcohol intake both with and without liver disease. Comparison of carbohydrate deficient transferrin with standard laboratory tests for alcohol abuse.
Setting-A teaching hospital unit with an interest in general medicine and liver disease.
Patients-22 "Self confessed" alcoholics admitting to a daily alcohol intake of at least 80 g for a minimum of three weeks; 15 of the 22 self confessed alcoholics admitted to hospital for alcohol withdrawal; 68 patients with alcoholic liver disease confirmed by biopsy attending outpatient clinics and claiming to be drinking less than 50 g alcohol daily; 47 patients with non-alcoholic liver disorders confirmed by biopsy; and 38 patients with disorders other than of the liver and no evidence of excessive alcohol consumption.
Intervention-Serial studies performed on the 15 patients undergoing alcohol withdrawal in hospital.
Main outcome measure-Determination of relative value of techniques for detecting alcohol abuse.
Results-Carbohydrate deficient transferrin was detected in 19 Patients with non-alcoholic liver disease (n=47)-Serum samples were taken from patients with a variety of non-alcoholic liver disorders. All of these disorders were confirmed histologically except in three patients with liver damage related to paracetamol, in whom the diagnosis was made on clinical and biochemical grounds alone. All patients were asked specifically about alcohol consumption and those with a daily intake of >20 g were excluded.
Controls without liver disease (n=38) were an unselected group of patients attending a general medical outpatient clinic. None had evidence of primary liver disease, though many had abnormal results of liver biochemical tests due to their illness. Patients were specifically questioned about alcohol consumption and only those admitting to <20 g a day were included.
LABORATORY INVESTIGATIONS
All patients had blood samples taken to detect carbohydrate deficient transferrin, for blood count, and for liver biochemistry profile. To test for carbohydrate deficient transferrin blood was taken into a sterile tube and allowed to clot before being centrifuged at 3000 rpm. The serum was stored at -200C before testing. Samples were tested under code, and all tests were carried out within three months after collection of the serum.
Routine laboratory markers for alcohol abuse that were investigated were mean corpuscular volume, ratio of aspartate to alanine aminotransferase activity, and y-glutamyltransferase activity. Mean corpuscular volume was estimated with a continuous flow automated haematology analyser (Technicon H 6000, Technicon Instruments, Basingstoke) with a sample of citrated blood. The remaining tests were performed with a multichannel autoanalyser (Technicon SMAC, Technicon Instruments, Basingstoke). Blood alcohol determinations were carried out with headspace gas liquid chromatography analysis. 7 Abnormal results were defined as those that fell outside the normal reference range for the laboratory. These were >98 fl for mean corpuscular volume8 and >45 U/I for y-glutamyltransferase activity.
CARBOHYDRATE DEFICIENT TRANSFERRIN
Carbohydrate deficient transferrin was identified by isoelectric focusing in agarose pH 3-10, with the transferrin bands being positively identified by immunofixation. Sorbitol (3-6 g) and agarose (0 3 g) (Pharmacia UK; Milton Keynes) were dissolved in BMJ VOLUME 299 12 AUGUST 1989 27 ml distilled water by boiling. The resultant solution was cooled to 75°C and 2 ml ampholine solution pH 3-10 (Pharmalyte, Pharmacia UK) added and mixed thoroughly. Gels were cast on to Gelbond film (Pharmacia UK) in a frame. 
Discussion
We have confirmed the results of earlier studies that carbohydrate deficient transferrin is valuable in identifying patients drinking excessive amounts of alcohol and have also shown its potential value in clinical medical practice. These findings are at variance with the study of Poupon et al, who found no significant difference in the pl 5 7 fraction of transferrin between alcoholic and non-alcoholic patients with cirrhosis." Their study, however, does not seem to have considered that abnormal transferrin disappears after alcohol withdrawal as there are no data on the time of testing in relation to alcohol consumption. False positive results are rarely found whereas most subjects consuming an average of 80 g of alcohol or more a day for at least three weeks showed a positive result irrespective of the nature or severity of the liver damage. Furthermore, the fact that the abnormal carbohydrate deficient transferrin remained detectable in the serum for several days after withdrawal of alcohol suggests that the test is superior to random blood alcohol determination (the only test hitherto available showing comparable specificity) in detecting abuse. Stibler et al reported four false positive results among 177 controls and noted that all were in elderly women." Interestingly, our single positive result among controls was in a 69 year old woman with chronic obstructive airways disease. No satisfactory information has been advanced for this apparent abnormality in elderly women.
The mechanism whereby the abnormal transferrin is produced is unknown. The electrophoretic mobility of transferrin seems to be altered by conditions in which the sialic acid residues on the carbohydrate terminals of the glycoprotein side chains of the transferrin molecule are altered. As the amounts of both sialic acid and carbohydrate depletion are uncertain we prefer the term "carbohydrate deficient" to desialylated transferrin.
In keeping with earlier observations our experience suggests that a daily consumption of 80 g of alcohol is required to produce a positive result. Although this is somewhat higher than the 60 g and 40 g recommended as being safe amounts for men and women respectively,'2 it nevertheless provides a means for detecting a substantial proportion of people who are at major risk from the harmful effects of alcohol. An estimated 400 000 people in the United Kingdom drink 80 g or more alcohol daily."
The the desialylated transferrin in relation to total transferrin. Their data do not suggest that this is superior to the carbohydrate deficient transferrin' that we measured and, though results may be obtained within a few hours, only one sample can be analysed at a time. Although serum samples may be safely tra'nsported, they should not be left at room temperature for more than two days before testing as this leads to shifts in the transferrin spectrum, probably due to the effect of naturally occurring bacterial neuraminidase.'4 We have also found that false positive results may be obtained if samples are stored at -20°C for 12 months or longer.
We found carbohydrate deficient transferrin to be more sensitive and specific than the more commonly used laboratory markers of alcohol abuse and probably superior to other tests that have been advocated. Chalmers et al advocated a combination of mean corpuscular volume, y-glutamyltransferase activity, and alkaline phosphatase activity, which yields a 70% specificity and 85% sensitivity.s Not only is this less specific than the abnormal carbohydrate deficient transferrin but it also requires several different laboratory determinations, thereby increasing the cost. We attempted to apply the formula to our patients and found it unhelpful, probably because of differences in the normal values for mean corpuscular volume and y-glutamyltransferase activity, which do not have international standards. The need for each laboratory to devise its own formula on the basis of local standard values would make this mathematical model even less attractive for clinical use. More recently, mitochondrial aspartate aminotransferase activity and the ratio of mitochondrial to total aspartate aminotransferase activity have been advocated as tests for alcoholism, but both fail to distinguish between alcoholic and non-alcoholic liver damage. 16 Our preliminary (unpublished) experience led us to use isoelectric focusing in agarose in preference to polyacrylamide as described by Stibler et al. ' She had normal hearing and was right handed. Ratings were consistent over the seven baseline days. The figure shows the results. The tapes of music, music and speech, and interesting speech reduced the hallucinations whereas the blank tape had little effect. The reduction was not sustained beyond the test with music or music and speech, but the effect of interesting speech persisted. An earplug in the left ear made little difference, but when an earplug was used in the right ear the hallucinations disappeared after the test but not during it. Hallucinations temporarily stopped while and after she wore a hearing aid.
